← Back to Search

Lipid Metabolism Modulator

High Saturated Fat Diet for Peripheral Vascular Disease

N/A
Recruiting
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy adults aged 18-40 years
English-speaking only
Must not have
Healthy individuals under 18 years or over 40 years of age
Heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 2
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study how artery and microvascular function is affected by eating fats with long or medium chain fatty acids.

Who is the study for?
This trial is for healthy, English-speaking adults aged 18-40 who are not pregnant. It's not suitable for those with blood pressure or heart rate outside of normal ranges, current tobacco users, lactose intolerant individuals, anyone with open mouth sores or wounds, diabetes patients, people with coronary artery disease or high cholesterol, recent chemotherapy patients, and non-English speakers.
What is being tested?
The study aims to see how a high fat meal affects the peripheral vascular function in participants. They will eat meals rich in long chain fatty acids (which may increase plasma ceramides) versus medium chain fatty acids (control). Their artery function and microvascular endothelial function will be measured using laser Doppler flowmetry and the CytoCam device.
What are the potential side effects?
While specific side effects aren't listed for consuming a single high-fat meal as part of this study, potential short-term reactions could include gastrointestinal discomfort such as bloating or indigestion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult between 18 and 40 years old.
Select...
I speak English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 or over 40 years old and healthy.
Select...
I have heart failure.
Select...
I have been diagnosed with coronary artery disease.
Select...
I have diabetes.
Select...
I have high blood pressure.
Select...
I have not had chemotherapy in the last 6 months.
Select...
I have visible sores or wounds in my mouth.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and year 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Endothelial-Dependent Total Vessel Density
Percentage of Cardiovascular Conductance
Secondary study objectives
Reactive Hyperemia

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Long Chain Fatty Acid High Fat MealExperimental Treatment1 Intervention
This arm will assess the effect of increased plasma ceramide on peripheral microvascular function after consuming a long chain fatty acid high fat meal.
Group II: Medium Chain Fatty Acid High Fat MealActive Control1 Intervention
This arm will assess the effect of increased plasma ceramide on peripheral microvascular function after consuming a medium chain fatty acid high fat meal.

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
628 Previous Clinical Trials
1,179,856 Total Patients Enrolled

Media Library

High Saturated Fat (Lipid Metabolism Modulator) Clinical Trial Eligibility Overview. Trial Name: NCT05107869 — N/A
Peripheral Vascular Disease Research Study Groups: Medium Chain Fatty Acid High Fat Meal, Long Chain Fatty Acid High Fat Meal
Peripheral Vascular Disease Clinical Trial 2023: High Saturated Fat Highlights & Side Effects. Trial Name: NCT05107869 — N/A
High Saturated Fat (Lipid Metabolism Modulator) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05107869 — N/A
~12 spots leftby Dec 2026